BioNeos Revenue and Competitors
Estimated Revenue & Valuation
- BioNeos's estimated annual revenue is currently $1.4M per year.
- BioNeos's estimated revenue per employee is $87,000
Employee Data
- BioNeos has 16 Employees.
- BioNeos grew their employee count by -16% last year.
BioNeos's People
Name | Title | Email/Phone |
---|---|---|
1 | Owner and President | Reveal Email/Phone |
2 | Owner | Reveal Email/Phone |
3 | VP Business Development | Reveal Email/Phone |
4 | CSO | Reveal Email/Phone |
5 | Software Developer | Reveal Email/Phone |
6 | Software Developer | Reveal Email/Phone |
7 | Software Developer | Reveal Email/Phone |
8 | Junior Software Engineer | Reveal Email/Phone |
BioNeos Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $0.4M | 5 | 25% | N/A | N/A |
#2 | $17.4M | 120 | 11% | N/A | N/A |
#3 | $2.8M | 28 | 12% | N/A | N/A |
#4 | $16.8M | 116 | -26% | N/A | N/A |
#5 | $12.5M | 86 | -1% | N/A | N/A |
#6 | $0.3M | 4 | -20% | N/A | N/A |
#7 | $5.6M | 48 | 4% | N/A | N/A |
#8 | $0.2M | 3 | N/A | N/A | N/A |
#9 | $9.4M | 72 | 31% | N/A | N/A |
#10 | $0.7M | 9 | N/A | N/A | N/A |
What Is BioNeos?
Bio::Neos, Inc. is a life sciences software company providing customized software solutions and bioinformatics data analysis to researchers. Based at the Oakdale Research Park in Coralville, Bio::Neos works with local and remote clients to provide their services across the nation. Bio::Neos specializes in data management, web applications, custom databases, mobile apps, custom software solutions, and high throughput bioinformatics data analysis.
keywords:N/AN/A
Total Funding
16
Number of Employees
$1.4M
Revenue (est)
-16%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $3.6M | 18 | -56% | N/A |
#2 | $4.5M | 20 | 5% | N/A |
#3 | $1.6M | 21 | 40% | $9M |
#4 | $2.2M | 22 | -8% | N/A |
#5 | $6.8M | 27 | 4% | N/A |